Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Feb 19;16(4):829.
doi: 10.3390/cancers16040829.

Clear Cell Renal Cell Carcinoma: A Test Bench for Investigating Tumor Complexity

Claudia Manini  1   2 , Estíbaliz López-Fernández  3   4 , Gorka Larrinaga  5   6   7 , José I López  7
Affiliations
Editorial

Clear Cell Renal Cell Carcinoma: A Test Bench for Investigating Tumor Complexity

Claudia Manini et al. Cancers (Basel). .

Abstract

Clear cell renal cell carcinoma (CCRCC), by far the most common renal cancer subtype, is an aggressive tumor variant, serving in recent years as a prolific test bench in cancer research [...].

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

See all similar articles

Cited by

References

    1. Noble R., Burley J.T., Le Sueur C., Hochberg M.E. When, why and how tumour clonal diversity predicts survival. Evol. Appl. 2020;13:1558–1568. doi: 10.1111/eva.13057. - DOI - PMC - PubMed
    1. Tippu Z., Au L., Turajlic S. Evolution of renal cell carcinoma. Eur. Urol. Focus. 2021;7:148–151. doi: 10.1016/j.euf.2019.12.005. - DOI - PubMed
    1. Pallikonda H.A., Turajlic S. Predicting cancer evolution for patient benefit: Renal cell carcinoma paradigm. Biochim. Biophys. Acta Rev. Cancer. 2022;1877:188759. doi: 10.1016/j.bbcan.2022.188759. - DOI - PubMed
    1. Panebianco M., Ciccarese C., Strusi A., Beccia V., Carbone C., Agostini A., Piro G., Tortora G., Iacovelli R. The role of the complement in clear cell renal cell carcinoma (ccRCC). What future prospects are there for its use in clinical practice? Cancers. 2024;16:490. doi: 10.3390/cancers16030490. - DOI - PMC - PubMed
    1. Posada Calderon L., Eismann L., Reese S.W., Reznik E., Ari Hakimi A. Advances in imaging-based biomarkers in renal cell carcinoma: A critical analysis of the current literature. Cancers. 2023;15:354. doi: 10.3390/cancers15020354. - DOI - PMC - PubMed

Publication types

LinkOut - more resources